| Literature DB >> 28486953 |
Claire Harris1,2, Kelly Allen3,4, Cara Waller4, Vanessa Brooke4.
Abstract
BACKGROUND: This is the third in a series of papers reporting a program of Sustainability in Health care by Allocating Resources Effectively (SHARE) in a local healthcare setting. Leaders in a large Australian health service planned to establish an organisation-wide, systematic, integrated, evidence-based approach to disinvestment. In order to introduce new systems and processes for disinvestment into existing decision-making infrastructure, we aimed to understand where, how and by whom resource allocation decisions were made, implemented and evaluated. We also sought the knowledge and experience of staff regarding previous disinvestment activities.Entities:
Keywords: De-adopt; De-list; Decision-making; Decommission; Disinvestment; Environmental scan; Health technology; Implementation; Resource allocation; TCP
Mesh:
Year: 2017 PMID: 28486953 PMCID: PMC5423420 DOI: 10.1186/s12913-017-2207-2
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1Overview of the SHARE Program
Fig. 2Framework for scanning taxonomy (adapted with permission from Harris et al. [94])
Fig. 3Framework for the process of resource allocation in a local health service
Structure and practice elements of components of organisational decision-making for resource allocation
| COMPONENTS | STRUCTURE (Who, What) | PRACTICE (How) |
|---|---|---|
| 1. Governance | ▪ Overseers | ▪ Oversight |
| 2. Administration | ▪ Administrators | ▪ Methods of administration, coordination, communication and collaboration |
| 3. Stakeholder engagement | ▪ Clinicians, Managers, Consumers, Technical experts, Funders, other relevant parties | ▪ Methods of identification, recruitment and engagement |
| 4. Resources | ▪ Funding sources | ▪ Provision of appropriate and adequate funding, time, skills/training, information |
| 5. Decision-making | ▪ Decision-makers | ▪ Methods of decision-making |
| 6. Implementation | ▪ Purchasers | ▪ Methods of purchasing |
| ▪ Policy and guidance developers | ▪ Methods of policy and guidance development | |
| ▪ Implementers | ▪ Methods of project management | |
| 7. Evaluation | ▪ Evaluators | ▪ Methods of evaluation |
| 8. (Reinvestment) |
|
|
aRequirement is used in the sense of performance stipulated in accordance with policies, regulations, standards or similar rules or obligations
bItems in italics were not specified by respondents but have been added for consistency across all components
Decision-makers and scope and types of decisions for resource allocation
| DECISION-MAKERS |
| Clinicians |
| Health practitioners delivering patient care. |
| Authorised individuals |
| Authorised individuals include Board Members, Executive Directors, Directors and Managers at all levels within the organisation. They are designated by their role in the organisation, for example ‘Director of Pharmacy’, rather than as a named individual ‘John Smith’. |
| Authorised groups |
| Authorised groups can be classified into those with |
| ▪ ongoing roles and responsibilities for decisions such as the Board, Executive Management Team, Standing Committees, Approved Purchasing Units and Profession-specific groups such as the Nursing Executive. |
| ▪ a specific, often time-limited, purpose such as a project Steering Committee, a Procurement Evaluation Committee to purchase a large piece of equipment and special initiatives like the High Cost Drugs Working Party of the Therapeutics Equivalence Program. |
| SCOPE OF DECISIONS |
| Clinicians make decisions for individual patients within the limits of parameters outlined in their position description, relevant professional standards and any local credentialing requirements. |
| Authorised individuals and groups make decisions on behalf of the organisation which impact on all patients, all staff or identified subgroups. |
| Individuals are authorised to make decisions on behalf of the organisation within a range of specified parameters outlined in their position description or the Authority Delegation Schedule. |
| Committees and other groups are authorised to make decisions on behalf of the organisation as stipulated in their Terms of Reference. |
| Examples of the parameters decision-makers are authorised to work within include, but are not limited to, location (eg South East sites), professional group (eg occupational therapists), specialty area (eg stomal therapy), patient group (eg children), nature of purchase or resource use (eg surgical equipment and consumables) and cost limit (eg up to $10,000). |
| TYPES OF DECISIONS |
| Clinical |
| ▪ Clinical decisions arise in the encounter between a health practitioner and an individual patient or client. Their purpose is to assess, treat and/or plan ongoing management of a health issue. |
| Strategic, operational or professional |
| ▪ Strategic decisions point the organisation in the direction it wants to go; they are captured in strategic goals and policies which reflect a particular position, priority or plan the organisation wishes to communicate to staff, patients and other stakeholders. Strategic planning is usually undertaken at organisation-level driven by the Board, Executive and Senior Managers but can also be undertaken at any level. |
| ▪ Operational decisions make the strategic goals happen; they enable day-to-day operations and are undertaken by managers at all levels. |
| ▪ Professional decisions address standards and methods of practice and are made by senior staff in the discipline to which they are relevant. |
| Routine, reactive or proactive |
| ▪ Routine decisions are made on a regular basis; examples include annual budget setting processes, monthly committee meetings and reviews of guidelines or protocols at specified intervals after their introduction. |
| ▪ Reactive decisions are made in response to situations as they arise; for example new legislation, product alerts and recalls, critical incidents and applications for new drugs to be included in the formulary. |
| ▪ Proactive decisions are driven by information that was actively sought for this purpose such as accessing newly published research evidence to compare against current practice or interrogating local data to ascertain practices with high costs or high rates of adverse events. |
| Conditional or unconditional |
| ▪ Conditional decisions specify requirements to be met before or after their implementation; for example availability of funding, clinical indications (eg disease/condition, severity, patient group), authorised practitioners (eg specific training, named individuals), monitoring of outcomes (eg patient outcomes, adverse events, costs), location (eg ICU, Hospital in the Home ), time limitation (eg until 2 year review). |
| ▪ Unconditional decisions have no requirements. |
| Allocating funds or non-monetary resources |
| ▪ Allocating funds involves spending money or putting it aside to purchase specified items later. |
| ▪ Allocating non-monetary resources can include rostering staff time; specifying health professional groups; providing clinic or operating room time; and developing protocols that direct use of clinical interventions, equipment, drugs, diagnostic tests and referral mechanisms. |
| Whether to buy or what, where and how to buy |
| ▪ ‘Whether to buy’ is a decision about what is required, for example a new drug to improve patient outcomes, a new scanner to reduce waiting time, consumables for a piece of equipment in current use. These decisions are undertaken by authorised individuals and some of the authorised groups such as Technology/Clinical Practice Committee, Therapeutics Committee, Falls Prevention Committee, etc. |
| ▪ ‘What, where and how to buy’ is a decision about how the requirement is met and considers product and manufacturer reliability, availability of parts and tools, service and maintenance contracts, IT requirements for hardware and software, price negotiations, etc. These decisions are undertaken by the Approved Purchasing Units and groups established for specific purchases. |
| Purchase of budgeted or unbudgeted items |
| ▪ Decisions to purchase budgeted items are made by the relevant authorised individual, usually the budget holder or their line manager depending on the purchase price and the designated cost limits of their respective approval levels (eg < $10,000, <$50,000). |
| ▪ Decisions to purchase unbudgeted items can only be approved by specified committees and Executive Directors |
Examples of criteria for resource allocation decisions
| WHETHER TO BUY | WHAT, WHERE AND HOW TO BUY | |||||
|---|---|---|---|---|---|---|
| Organisation-wide Committee | Program Committee | Department | Individual decision-makers | Approved Purchasing Units | Organisation-wide Committee | Department |
| Introduction of new health technologies and clinical practices | Purchase of capital equipment | Purchase of capital equipment | Determination of clinical practices and purchase of clinical equipment | General purchasing | Purchase of clinical consumables | Purchase of pharmaceuticals |
| Explicit criteria required for decision-making | Criteria ‘usually’ considered | Theoretical ‘ideal’ criteria developed in workshop (different to criteria used in current practice) | Criteria ‘usually’ considered | Criteria ‘usually’ considered | Criteria ‘usually’ considered | Criteria ‘usually’ considered |
| ▪ Conflict of interest (Applicant and Committee members) | ▪ Equipment serviceability and impact | ▪ Workload management | ▪ Quality and safety/clinical risk | All APU purchase decisions are made with commercial/financial consideration including | ▪ Price | ▪ Labelling |
Examples of types and sources of evaluation data used by committees
| Process (implementation) and Impact (practice change) |
| ▪ Progress Reports for new TCPs including number of patients treated, number waiting, new referrals (6 monthly) |
| ▪ Medication safety audits (twice yearly) |
| ▪ Continual Review Evaluation through Australian Council of Healthcare Standards Guide (dates in Nursing Strategic Plan) |
| ▪ Established surveillance mechanisms of transfusion practices (ongoing) |
| ▪ Audits of transfusion practice (random, on behalf of Department of Human Services) |
| ▪ Incident reports (as they arise, documented in Riskman software) |
| Practitioner outcomes |
| ▪ Survey/interview data including user satisfaction and comments (after project implementation) |
| ▪ Clinical practice audits (quarterly) |
| ▪ Incident reports (as they arise, documented in Riskman software) |
| Patient outcomes |
| ▪ Progress Reports for new TCPs including patient outcomes and adverse events (6 monthly) |
| ▪ Reports of adverse events related to new TCPs (at the time of occurrence) |
| ▪ Infection Control surveillance mechanisms (ongoing) |
| ▪ Incident reports (as they arise, documented in Riskman software) |
| Economic outcomes |
| ▪ Clinical Information Management databases of routinely-collected data used to assess |
| − Cost of falls and falls-related injuries (as required) |
| − Cost of increased length of stay (as required) |
| − Costs of products (as required) |
| − Costs of procedures (as required) |
| System outcomes |
| ▪ Applications for new TCPs including anticipated implications of new TCP on other areas such as intensive care or pharmacy |
| ▪ Reports of 2 year review after introduction of new TCP including actual implications of new TCP on other areas |